Combination therapy with daily interferon alpha and ribavirin in naive patients with chronic hepatitis C.

被引：0
|
作者：
Rothstein, KD [1 ]
Suvannasankha, A [1 ]
Digreggorio, K [1 ]
Gross, F [1 ]
Peikin, S [1 ]
Mushnick, A [1 ]
Deangelo, C [1 ]
Salowe, D [1 ]
Siegel, H [1 ]
Shaw, E [1 ]
Bond, K [1 ]
Manzarbeitia, C [1 ]
机构：
[1] Albert Einstein Med Ctr, Philadelphia, PA 19141 USA
来源：
HEPATOLOGY | 1999年 / 30卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1836
引用
收藏
页码：619A / 619A
页数：1
相关论文
共 50 条
  • [1] Efficacy of daily interferon-alpha in combination with ribavirin in the treatment of naive patients MQTH chronic hepatitis C.
    Urbanek, P
    HEPATOLOGY, 2002, 36 (04) : 578A - 578A
  • [2] Combination therapy with low dose interferon and ribavirin in naive patients with hepatitis C.
    Martin, A
    Canchis, PW
    Tamburro, CH
    Fortwengler, P
    Cecil, B
    Cox, A
    Adler, E
    Miller, B
    Chene, B
    Hiser, M
    HEPATOLOGY, 1999, 30 (04) : 620A - 620A
  • [3] Combination therapy with interferon alpha-2b and ribavirin in naive patients with chronic hepatitis C
    Juszczyk, J
    Bolewska, B
    Cianciara, J
    Jablonska, J
    Zaborowski, P
    Niedzialek, D
    Gladysz, A
    Piszko, P
    JOURNAL OF HEPATOLOGY, 2000, 32 : 199 - 199
  • [4] The effect of interferon alfa and ribavirin combination therapy in naive patients with chronic hepatitis C
    Chemello, L
    Cavalletto, L
    Bernardinello, E
    Guido, M
    Pontisso, P
    Alberti, A
    JOURNAL OF HEPATOLOGY, 1995, 23 : 8 - 12
  • [5] Effect of combination therapy of interferon alpha and ribavirin in the patients with chronic hepatitis C
    Kim, Seok Hyn
    Lee, Byung Seok
    Lee, Heon Young
    Lee, Tae Hee
    Kang, Young Woo
    Park, Jeong Hoon
    Kim, Hong Su
    Kim, Suk Bae
    Song, Il Han
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 21 : A467 - A467
  • [6] Comparison of daily induction dose interferon alpha 2b plus ribavirin followed by daily combination therapy versus standard combination therapy in treatment naive patients with chronic hepatitis C.
    Lawitz, EJ
    Kadakia, SC
    Cantu, N
    Jeffries, MA
    Schutz, SM
    Matossian, H
    Jolley, JJ
    Sheinbaum, AJ
    Meadows, JG
    GASTROENTEROLOGY, 2000, 118 (04) : A1461 - A1461
  • [7] A randomized trial to assess the efficacy of interferon-alpha daily in combination with ribavirin in the treatment of naive patients with chronic hepatitis C
    Tassopoulos, NC
    Ketikoglou, I
    Tsantoulas, D
    Raptopoulou, M
    Hatzis, G
    Vafiadis, I
    Sidiropoulos, L
    Kanatakis, S
    Anagnostopoulos, G
    Sypsa, V
    Hatzakis, A
    JOURNAL OF VIRAL HEPATITIS, 2003, 10 (05) : 383 - 389
  • [8] Combination of interferon (IFN) induction therapy and ribavirin in chronic hepatitis C.
    Ferenci, P
    Brunner, H
    Vogel, W
    Gschwantler, M
    Datz, C
    Hackl, F
    Steindl-Munda, PE
    Hofer, H
    Mueller, C
    Mueller, C
    GASTROENTEROLOGY, 2000, 118 (04) : A961 - A961
  • [9] Daily administration of interferon alpha 2b and utility of combination therapy with ribavirin as initial treatment for chronic hepatitis C.
    Ricchiuti, A
    Ciccorossi, P
    Costa, F
    Bellini, M
    Carrara, PD
    Arpe, P
    Maggi, F
    Vatteroni, ML
    Bendinelli, M
    Maltinti, G
    Marchi, S
    HEPATOLOGY, 1999, 30 (04) : 627A - 627A
  • [10] High sustained response to daily dosing of interferon with ribavirin in chronic hepatitis C patients naive to therapy
    Abbas, Z
    Hamid, S
    Tabassum, S
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2002, 17 (05) : 577 - 581
12345